• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,722.39 458.06
( 0.60%)
Global Indices
Nasdaq
51,705.57 482.31
(0.94%)
Dow Jones
7,575.20 122.74
(1.65%)
Hang Seng
69,393.70 76.20
(0.11%)
Nikkei 225
10,435.69 -36.03
(-0.34%)
Forex
USD-INR
94.92 -0.57
(-0.60%)
EUR-INR
109.83 -0.42
(-0.38%)
GBP-INR
127.25 -0.49
(-0.38%)
JPY-INR
0.59 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Neuland Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524558
INE794A01010
1453.5908993
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NEULANDLAB
60.24
21873.61
EPS(TTM)
Face Value()
Div & Yield %
283.01
10
0.2
 
( Cr)
ParticularsMar 2026 ( Cr)Dec 2025 ( Cr)Sep 2025 ( Cr)
Gross Sales776.25439.71514.27
Other Operating Income0.000.000.00
Other Income 12.468.051.80
Total Income788.71447.76516.07
Total Expenditure 469.35362.78359.15
PBIDT319.3684.98156.92
Interest 7.236.795.34
PBDT312.1378.19151.58
Depreciation25.0923.9222.54
Tax76.8015.2132.51
Fringe Benefit Tax0.000.000.00
Deferred Tax-2.28-1.350.07
Reported Profit After Tax212.5240.4296.46
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item212.5240.4296.46
EPS (Unit Curr.)165.6531.5075.18
EPS (Adj) (Unit Curr.)165.6531.5075.18
Calculated EPS (Unit Curr.)164.7431.3374.77
Calculated EPS (Adj) (Unit Curr.)164.7431.3374.77
Calculated EPS (Ann.) (Unit Curr.)658.96125.31299.09
Calculated EPS (Adj) (Ann.) (Unit Curr.)658.96125.31299.09
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity12.9012.9012.90
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)41.1419.3330.51
PBDTM(%)40.2117.7829.47
PATM(%)27.389.1918.76